Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11983-11991, Vol. 75, No. 24
Department of Internal Medicine, The
University of Texas Southwestern Medical Center, Dallas, Texas
75390-91131; Ecology & Evolution, ETH
Zurich, CH-8092 Zurich, Switzerland2; and
Vaccine and Gene Therapy Institute, Oregon Health Sciences
University, Portland, Oregon 97201-30983
Received 3 July 2001/Accepted 17 September 2001
Human immunodeficiency virus (HIV)-specific T-cell responses are
thought to play a key role in viral load decline during primary infection and in determining the subsequent viral load set point. The
requirements for this effect are unknown, partly because comprehensive analysis of total HIV-specific CD4+ and CD8+
T-cell responses to all HIV-encoded epitopes has not been accomplished. To assess these responses, we used cytokine flow cytometry and overlapping peptide pools encompassing all products of the HIV-1 genome
to study total HIV-specific T-cell responses in 23 highly active
antiretroviral therapy naïve HIV-infected patients.
HIV-specific CD8+ T-cell responses were detectable in all
patients, ranging between 1.6 and 18.4% of total CD8+ T
cells. HIV-specific CD4+ T-cell responses were present in
21 of 23 patients, although the responses were lower (0.2 to 2.94%).
Contrary to previous reports, a positive correlation was identified
between the plasma viral load and the total HIV-, Env-, and
Nef-specific CD8+ T-cell frequency. No correlation
was found either between viral load and total or Gag-specific
CD4+ T-cell response or between the frequency of
HIV-specific CD4+ and CD8+ T cells. These
results suggest that overall frequencies of HIV-specific T cells are
not the sole determinant of immune-mediated protection in
HIV-infection.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.11983-11991.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Analysis of Total Human Immunodeficiency Virus (HIV)-Specific
CD4+ and CD8+ T-Cell Responses: Relationship
to Viral Load in Untreated HIV Infection
*
Corresponding author. Mailing address: Vaccine Research
Center, NIAID/NIH, Building 40, Room 3614B, 40 Convent Dr., MSC 3022, Bethesda, MD 20892. Phone: (301) 594-8612. Fax: (301) 480-2779. E-mail:
mbetts{at}nih.gov.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|